戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 is some 50% larger with polylysine than with polyarginine.
2 c TAT, different TAT variants, Antp, MTS and polyarginine.
3 as mimicked by the CaR agonists spermine and polyarginine.
4 ) molecular clone was effectively blocked by polyarginine.
5 ion reactions were faster in the presence of polyarginine.
6 cence polarization signal in the presence of polyarginine.
7 igher in the presence than in the absence of polyarginine.
8 ze the transfer of ADP-ribose from NAD(+) to polyarginine.
9 possess inhibitory potency almost equal to L-polyarginines.
10  to 140% of the control in the presence of l-polyarginines.
11        Using five SPPs (SPACE peptide, TD-1, polyarginine, a dermis-localizing peptide and a skin pen
12 evidence indicate that HvnA and HvnB mediate polyarginine ADP-ribosylation not by ARTase activity, bu
13  performing the reactions in the presence of polyarginine and continuously measuring the fluorescence
14 quences were covered by subsequent layers of polyarginine and hyaluronic acid, thereby creating multi
15        We have prepared vesicles composed of polyarginine and polyleucine segments that are stable in
16 ptides with cationic polyamino acids such as polyarginine and polylysine by fluorescence polarization
17   A previously proposed model for binding of polyarginine and protamine to DNA provides a convenient
18                           Three SPPs (SPACE, Polyarginine and TD-1) significantly enhanced CsA penetr
19 cant permeation enhancing ability than other polyarginines and TAT peptides.
20  inhibited by CK2 effectors such as heparin, polyarginine, and histone H1, but was not affected by th
21 tial reading frames, generating polyproline, polyarginine, and polyalanine proteins, respectively.
22 ed cationic sequence derived from HIV Tat or polyarginine Arg8, and equals that of hydrocarbon-staple
23 ll, we show that modifying cyclotides with a polyarginine backbone can enhance the delivery of therap
24                      Cellular association of polyarginine-based, cell-penetrating peptides (CPPs) is
25  and HvnB catalyzed ribosylation of not only polyarginine but also polylysine and polyhistidine, and
26 ine, but not asparagine, within a stretch of polyarginine can mediate high-affinity binding.
27 n, as illustrated by selective attachment of polyarginine cargoes to enhance the uptake of proteins i
28 -terminus of ubiquitin and employed a cyclic polyarginine cell-penetrating peptide (cR(10)) conjugate
29 esent study was to investigate the effect of polyarginine chain length on topical delivery of surface
30 the shell of MUA-Au NCs-MTX-Affibody (MAMA), polyarginine chains of affibody could be digested by try
31  artificial cerebrospinal fluid (aCSF) using polyarginine-coated nanodiamonds (PA-coated NDs) as affi
32 oxic to the cells than the corresponding PNA-polyarginine conjugate.
33 ved that inside the voltage-biased nanopore, polyarginine-conjugated DNA-PNA duplexes dehybridize fas
34 his work, comparative studies on DNA-PNA and polyarginine-conjugated DNA-PNA duplexes unzipping insid
35 yarginine peptides showed that inhibition by polyarginine-containing peptides appeared to depend on t
36                                              Polyarginine-containing peptides represent potent inhibi
37                              Here, we tested polyarginine for inhibition of productive human immunode
38 odified the MCoTI-II cyclotide backbone with polyarginines for enhanced intracellular delivery and gr
39  caused by mutations in KRT1, showing that a polyarginine frameshift in the keratin-1 tail can also c
40 -Arg-Arg-Arg-Arg-Arg or longer iterations of polyarginine have been shown to be competitive inhibitor
41              Polycations such as polylysine, polyarginine, histone H1, histones H2A-H2B, and protamin
42                                We found that polyarginine inhibited significantly human immunodeficie
43                                              Polyarginine insertions in place of residues 24 to 60 th
44                  We found that incorporating polyarginines into the cyclotide backbone significantly
45                     The therapeutic use of D-polyarginines is especially interesting because they are
46               Positively charged peptides of polyarginine mimicked the effect of apoE-rich HDL in red
47                                          The polyarginine moiety of affibody sealed methotrexate (MTX
48 everal CPPs in prostate cancer cell lines, a polyarginine peptide (R11) seemed to be the best deliver
49 r of alpha-syn aggregation (ASID), using the polyarginine peptide delivery system.
50 dentity of the cationic amino acid, with the polyarginine peptide giving the most favourable Delta G
51 ds are capable of mediating the transport of polyarginine peptides across membranes.
52 ort that the cytosolic penetration of linear polyarginine peptides is dependent on the oxidation stat
53               Structure-function analyses of polyarginine peptides showed that inhibition by polyargi
54 sidechain binding enthalpies (polyhistidine, polyarginine, polylysine), weighted by numbers of such c
55 olyglycine (polyG), polyalanine (polyA), and polyarginine (polyR) inclusions, leading to behavioral d
56 ng a fluorogenic assay, we demonstrated that polyarginine potently inhibited substrate-specific prote
57 ) values of five macromolecules: polylysine, polyarginine, protamine, low-density lipoprotein (LDL),
58 ting human immunodeficiency virus-1 and that polyarginine represents a lead example of such inhibitor
59                          Here, we utilized a polyarginine-rich, cell-permeable peptide that represent
60 n pairing influences protein stability using polyarginine salts as a model system.
61 kable feature of these materials is that the polyarginine segments both direct structure for vesicle
62                                     However, polyarginine substitutions expanded the RNA binding spec
63 imal helix-like motif sequence (RLLRLLR) and polyarginine tail length (R(7)) for cargo delivery.
64  effect of cargo, helix-like motif sequence, polyarginine tail length, and peptide stereochemistry on
65 CL peptide contains a helix-like motif and a polyarginine tail.
66 cation studies showed that the most potent D-polyarginine tested was nona-D-arginine (D9R) amide with
67                 PC2 was not inhibited by any polyarginine tested; indeed, PC2 showed an increase in a
68 d to determine the important elements within polyarginines that contribute to effective inhibition.
69 ific, as indicated by lack of effects by the polyarginine vehicle alone or a scrambled sequence of th
70                                              Polyarginine was found to have no effect on the rate of
71 tly, a series of non-amidated and acetylated polyarginines was synthesized.
72 zymes, the reaction rates in the presence of polyarginine were found to be sensitive to the presence